Combretastatin A4 phosphate
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Combretastatin A4 phosphate, covering 2010-06-11 to 2017-12-06. Get the full timeline:
Most recent: Clinical Trial Update: Combretastatin A4 Phosphate in Patients With Neovascular Age-Related Macular Degeneration [Phase 1, Phase 2]